Approval of the First CRISPR-Cas9 Gene Editing Therapy for Sickle Cell Disease
- PMID: 39360998
- DOI: 10.1093/clinchem/hvae038
Approval of the First CRISPR-Cas9 Gene Editing Therapy for Sickle Cell Disease
MeSH terms
LinkOut - more resources
Full Text Sources
Medical